IPO Newsroom(@IPONewsroom_):CITY THERAPEUTICS PRICES UPSIZED IPO AT $18 A SHARE, RAISING ABOUT $200 MILLION The RNAi drug developer sold 11.1M shares and is expected to begin trading on Nasdaq on Oct. 16 under $CTY, with Goldman Sachs, Jefferies and Stifel among the bookrunners, per the company

IPO Newsroom

@IPONewsroom_

Your IPO newsroom. S-1 filings, pricing updates, debut coverage, and post-IPO performance.

Joined November 2024

109 Following 31.1K Followers

IPO Newsroom@IPONewsroom_

2026.10.16 02:39

CITY THERAPEUTICS PRICES UPSIZED IPO AT $18 A SHARE, RAISING ABOUT $200 MILLION The RNAi drug developer sold 11.1M shares and is expected to begin trading on Nasdaq on Oct. 16 under $CTY, with Goldman Sachs, Jefferies and Stifel among the bookrunners, per the company